Hepatology - European Medical Journal

Continue

Hepatology

Abstracts
10 Mins
3rd August 2023

EASL 2023 Abstract Highlights

The following selected abstracts were the pinnacle of those showcased at the European Association for the Study of the Liver (EASL)…
EMJ Hepatology 10.1 Feature Image
2 Mins
4th August 2022

Prescription Event Monitoring of Checkpoint Inhibitor-Induced Liver Injury and Outcomes of Rechallenge: A 10-Year Experience

The definition and severity of checkpoint inhibitor-induced liver injury (ChILI) have been reported using the Common Terminology Criteria for Adverse Events (CTCAE) used in cancer therapy.
EMJ Hepatology 10.1 Feature Image
3 Mins
4th August 2022

Management of Severe, Steroid-Resistant and Steroid-Refractory Hepatotoxicity in Patients Treated with Checkpoint Inhibitor Immunotherapy

Checkpoint inhibitor immunotherapy (ICI) has revolutionised cancer care but is associated with immune-related toxicities, which may require ICI discontinuation and immunosuppressive therapies (IST).
EMJ Hepatology 10.1 Feature Image
2 Mins
4th August 2022

Pre-transplant Changes in Serum Protein Glycosylation Relates to Risk of Hepatocellular Carcinoma Recurrence After Liver Transplantation and Provide a Potential Prognostic Biomarker: A Proof-of-Concept Study

Hepatocellular carcinoma (HCC) recurs after liver transplantation (LT) in approximately 10% of patients. Changes in protein glycosylation have been described during the development of HCC and are associated with progressive disease and early mortality.
EMJ Hepatology 9.1 Feature Image
1 Mins
5th August 2021

Prevalence and Prognostic Value of Cirrhotic Cardiomyopathy as Defined According with the Proposed New Classification

The prevalence and prognostic relevance of cirrhotic cardiomyopathy (CCM), as defined according with the new core criteria proposed in 2019…
EMJ Hepatology 9.1 Feature Image
2 Mins
5th August 2021

Referral of Patients with Non-alcoholic Fatty Liver Disease with Significant Fibrosis from Primary Care to Secondary Care in Belgium

Non-alcoholic fatty liver disease (NAFLD) is becoming the most frequent cause of chronic liver disease worldwide. The stage of fibrosis…
EMJ Hepatology 9.1 Feature Image
2 Mins
5th August 2021

MicroRNA-27a-3p Modulates FoxO1 to Induce Tumour-Like Phenotypes in Bile Ducts

The authors analyse the miR landscape of CCA and non-malignant livers to define their roles in orchestrating gene regulation and promoting CCA development.
EMJ Hepatology 9.1 Feature Image
3 Mins
5th August 2021

A MET-Agonistic Antibody Mimicking Hepatocyte Growth Factor Accelerates Liver Regeneration and Improves Survival in Mice Undergoing Carbon Tetrachloride Exposure and Partial Hepatectomy

Small-for-size syndrome (SFSS) is defined by prolonged cholestasis, coagulopathy, and ascites within the first week of liver…